Deniz KOR, Berna Şeker YILMAZ, Fatma Derya BULUT, Sebile KILAVUZ, Murat ÖKTEM, Serdar CEYLANER, Dinçer YILDIZDAŞ, Neslihan Önenli MUNGAN

Clinical features of 27 Turkish Propionic acidemia patients with 12 novel mutations

Propionic acidemia (PA) is an inherited metabolic disease caused by thedeficiency of one of the four biotin-dependent enzymes propionyl-CoAcarboxylase (PCC), and is characterized by coma and death in unrecognizedpatients, additionally late diagnosis leads to severe developmental delayand neurological sequels. Manifestations of PA over time can includegrowth impairment, intellectual disability, seizures, basal ganglia lesions,pancreatitis, and cardiomyopathy. Other rarely reported complications includeoptic atrophy, hearing loss, premature ovarian insufficiency, and chronic renalfailure. Mutations in PCCA-PCCB genes cause the clinically heterogeneousdisease of PA. In this study, we investigate the mutation spectrum of PCCAPCCB genes and phenotypic features of 27 Turkish patients with PA from theSouth and Southeast parts of Turkey. We report 12 novel PA mutations, fiveaffecting the PCCA gene and 7 affecting the PCCB gene.

PDF

___

1. Hsia YA, Scully KJ, Rosenberg LE. Inherited propionyl-CoA carboxylase deficiency in “ketotic hyperglycinemia”. J Clin Invest 1971; 50: 127-130.

2. Fenton WA, Gravel RA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism. In: Scriver C, Beaudet A, Sly W, Valle D (eds.) The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001; 2165-2190.

3. Huang CS, Sadre-Bazzaz K, Shen Y, Deng B, Zhou ZH, Tong L. Crystal structure of the alpha (6) beta (6) holoenzyme of propionyl-coenzyme A carboxylase. Nature 2010; 466: 1001-1005.

4. Lamhonwah AM, Barankiewicz TJ, Willard HF, Mahuran DJ, Quan F, Gravel RA. Isolation of cDNA clones coding for the alpha and beta chains of human propionyl-CoA carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA and PCCB genes. Proc Natl Acad Sci U S A. 1986; 83: 4864-4868.

5. Chapman KA, Bush WS, Zhang Z. Gene expression in cell lines from propionic acidemia patients, carrier parents, and controls. Mol Genet Metab 2015; 115: 174-179.

6. Sutton VR, Chapman KA, Gropman AL, et al. Chronic management and health supervision of individuals with propionic acidemia. Mol Genet Metab 2012; 105: 26-33.

7. Baumgartner MR, Horster F, Carlo Dionisi-Vici, et al. Proposed guidelines for the diagnosis and management of methyl-malonic and propionic acidemia. Orphanet J Rare Dis 2014; 9: 130.

8. Pena L, Franks J, Chapman KA, et al. Natural history of propionic acidemia. Mol Genet Metab 2012; 105: 5-9.

9. Sass JO, Hofmann M, Skladal D, Mayatepek E, Schwahn B, Sperl W. Propionic acidemia revisited: a workshop report. Clin Pediatr (Phila) 2004; 43: 837- 843.

10. Van der Meer SB, Poggi F, Spada M, et al. Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr 1996; 155: 205-210.

11. Rafique M. Clinical Spectrum of Propionic Acidaemia. J Nutr Metab 2013; 1-6.

12. McCrory NM, Edick MJ, Ahmad A, et al; Inborn Errors of Metabolism Collaborative. Comparison of methods of initial ascertainment in 58 cases of propionic acidemia enrolled in the Inborn Errors of Metabolism Information System reveals significant differences in time to evaluation and symptoms at presentation. J Pediatr 2017; 180: 200-205.e8.

13. Grünert SC, Müllerleile S, de Silva L, et al. Propionic acidemia: neonatal versus selective metabolic screening. J Inherit Metab Dis 2012; 35: 41-49.

14. Lehnert W, Sperl W, Suormala T, Baumgartner ER. Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients. Eur J Pediatr 1994; 153(Suppl 1): S680S80.

15. Walter JH, Wraith JE, and Cleary MA. Absence of acidosis in the initial presentation of propionic acidaemia. Arc DisChild Fetal Neonatal Ed 1995; 72: F197-199.

16. Surtess RA, Matthews EE, Leonard JV. Neurologic outcome of propionic acidemia. Pediatr Neurol 1992; 8: 333-337.

17. Kraus JP, Spector E, Venezia S, et al. Mutation analysis in 54 propionic acidemia patients. J Inherit Metab Dis 2012; 35: 51-63.

18. Desviat LR, Perez B, Perez-Cerda C, RodríguezPombo P, Clavero S, Ugarte M. Propionic acidemia: mutation update and functional and structural effects of the variant alleles. Mol Genet Metab 2004; 83: 28- 37.

19. Perez B, Desviat LR, Rodriguez-Pombo P, et al. Propionic acidemia: identification of twenty-four novel mutations in Europe and North America. Mol Genet Metab 2003; 78: 59-67.

20. Gupta D, Bijarnia-Mahay S, Kohli S, et al. Seventeen Novel Mutations in PCCA and PCCB Genes in Indian Propionic Acidemia Patients, and Their Outcomes. Genet Test Mol Biomarkers 2016; 20: 373-82.

21. Chen Z, Wen P, Wang G, et al. Analysis of PCCA and PCCB gene mutations in patients with propionic acidemia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2015; 32: 26-30.

22. Vatanavicharn N, Liammongkolkul S, Sakamoto O, Kamolsilp M, Sathienkijkanchai A, Wasant P. Clinical characteristics and mutation analysis of propionic acidemia in Thailand. World J Pediatr 2014; 10: 64- 68.